BFRI logo

BIOFRONTERA INC

BFRINASDAQ
๐Ÿ† #4769 by market capEarnings Mar 16 ยท PostUS Equity
$0.53โ–ผ $0.04 (โˆ’7.00%)
Market closed ยท at close
๐Ÿ””
Track BFRI
Get earnings, price moves & breaking news on Telegram
Track
24hโ–ผ 7.0%
7dโ–ผ 24.5%
14dโ–ผ 36.9%
30dโ–ผ 33.2%
ytdโ–ผ 11.6%
1yโ–ผ 28.4%
๐ŸฆMarket Cap
$8M
Small Cap
๐Ÿ“ˆRevenue Growth (YoY)
17.8%
Healthy
๐Ÿ“ŠGross Margin
79.3%
High
๐Ÿ’ตFCF Margin
โ€”
โš–๏ธP/S Ratio
0.2x
Cheap
Otter Score
โ€”
Insufficient data

Trading Snapshot

Day Range
$0.53 โ€“ $0.54
52-Week Range
$0.54 โ€“ $1.66
Volume (shares)
2,626
Avg Volume (shares)
โ€”
Shares Outstanding
14.8M
Next Earnings
2027-03-16

Fundamentals Snapshot

Annual Revenue
$42M
Last Q Revenue
$9M
P/E Ratio
โ€”
P/S Ratio
0.2x
EPS (TTM)
$-0.59
Dividend Yield
โ€”
BFRI logo

BIOFRONTERA INC

BFRI
Financial Trends

Financial history unavailable.

StockOtter ยท stockotter.space

About BIOFRONTERA INC

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.

๐Ÿฆฆ

Otter Score Breakdown

How it's scoredFive components, each rated 1โ€“5โ˜… and equally weighted (20%), averaged to a 0โ€“100 score:๐Ÿ’Ž Quality โ€” gross margin๐Ÿš€ Growth โ€” revenue YoYโš–๏ธ Valuation โ€” P/S ratioโšก Momentum โ€” 30-day price change๐Ÿ’ง Dilution โ€” 1-yr share issuance (buybacks score higher)

Insufficient data for all five components.

๐Ÿ’ŽQualityโ˜…โ˜…โ˜…โ˜…โ˜…
๐Ÿš€Growthโ˜…โ˜…โ˜…โ˜…โ˜…
โš–๏ธValuationโ˜…โ˜…โ˜…โ˜…โ˜…
Overall Score
Insufficient data
โ€”/100

Analyst Ratings

โ“˜
Consensus
Buy
8 analysts
Strong Buy2
Buy5
Hold1
Sell0
Strong Sell0
Ratings as of Nov 2026

Latest News & Updates

News unavailable.